Will Plan B ever be?

NewsGuard 100/100 Score

The Plan B "morning-after" pill is in the news again following a modified request for federal approval for the pill to be sold without a prescription.

Barr Laboratories, Inc. and the Food and Drug Administration (FDA) both say the company has resubmitted the Plan B application but have declined to comment on the contents.

Last month, the agency urged Barr to reapply to sell the emergency contraceptive without a prescription to women 18 and older but wants details on how pharmacists would enforce the age restrictions on such sales.

The company had originally sought approval to sell Plan B over the counter without an age limit but later revised the request to 16 and older at the FDA's suggestion.

The drug can prevent pregnancy if taken within 72 hours of sexual intercourse.

The approval for access to the pill has stalled at the FDA for years and has engendered determined lobbying by supporters and opponents amid accusations of political influence.

Some Democrat senators, among them Hillary Clinton, have blocked the confirmation of the new Commissioner of the FDA, Andrew von Eschenbach, over the issue.

Supporters of the pill say wider availability could reduce the number of abortions, while opponents argue it may increase promiscuity, particularly among teenagers.

The FDA said earlier this month it was prepared to quickly approve Plan B if Barr increased the age it proposed for over-the-counter sales from 16 to 18 and met other conditions.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Renaissance of "food as medicine" in modern clinical trials